Lv2
198 积分 2024-07-02 加入
BD PhaSeal™ and particulate contamination
2天前
已完结
Determination of Holdup Volume and Transient Contact Compatibility of Closed System Transfer Devices for a Reconstituted Lyophilized Drug Product
2天前
已完结
Comparison of closed system transfer devices for turnaround time and ease of use
2天前
已完结
Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal®, or no closed system transfer device for administration of cancer chemotherapy to a dog model
2天前
已完结
Use of a closed-system drug transfer device (PhaSeal) and impact on preparation time
2天前
求助中
An Industry Perspective on the Challenges of Using Closed System Transfer Devices with Biologics and Communication Guidance to Healthcare Professionals
2天前
已完结
A Systematic Approach to Evaluating Closed System Drug-Transfer Devices During Drug Product Development
3天前
已完结
Evaluation of Different Quality-Relevant Aspects of Closed System Transfer Devices (CSTDs)
3天前
已完结
Strategies for high‐concentration drug substance manufacturing to facilitate subcutaneous administration: A review
12天前
已完结
Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation
12天前
已完结
皖公网安备34019202002308
